How Much Does IVF Cost? What to Realistically Budget

A single IVF cycle in the United States typically runs between about $15,000 and $25,000 once you factor in medications, monitoring, and lab fees on top of the base procedure. A multicenter prospective study of American fertility patients found median out-of-pocket expenses of roughly $19,000 for those using IVF, making it the most expensive category of fertility treatment by a wide margin.¹ That number, though, is just the starting point. What you realistically budget depends on how many cycles you need, which add-on procedures your clinic recommends, your age, and whether any insurance or employer benefit covers part of the tab.

What a Single Cycle Costs in the US Versus Elsewhere

The roughly $19,000 median out-of-pocket figure from U.S. data covers the core IVF procedure, monitoring ultrasounds, bloodwork, egg retrieval, fertilization, and embryo transfer.¹ But IVF pricing varies enormously around the world. In India, for example, average out-of-pocket costs for a cycle came to about $1,900, with public facilities averaging around $1,300 and private clinics closer to $2,800.² Turkey has also emerged as a destination where IVF costs remain substantially lower than in the United States even after you add travel and accommodation expenses.³

These differences are not just about labor costs or overhead. Countries with publicly funded healthcare systems often subsidize some or all IVF cycles for eligible patients, which squeezes clinic pricing downward across the board. In the U.S., the absence of a universal subsidy means you’re absorbing the full market rate for clinic services, anesthesia, and lab work. If your clinic quotes a “base cycle” fee of $12,000 to $15,000, that number almost always excludes medications, genetic testing, and embryo freezing, which are the line items that push the total into the $20,000-plus range.

Fertility Medications Are a Separate Budget Line

One of the most common surprises for first-time IVF patients is the medication bill. The injectable hormones used for ovarian stimulation are expensive, and the specific protocol your doctor chooses makes a real difference. A cost analysis across two large clinical trials found that switching from one type of stimulation drug to another saved about £253 per cycle on average, enough to fund one extra cycle for roughly every ten completed.⁴ In the U.S., injectable gonadotropins alone commonly cost $3,000 to $6,000 per cycle depending on the dose and your pharmacy.

The dose itself is the biggest variable. Your doctor calibrates it based on your ovarian reserve, age, and how your body responds. A woman who needs higher doses due to a lower reserve will pay more for the same drug. If you’re comparing quotes from different clinics, always ask whether medication costs are included, what protocol they’re recommending, and what the estimated total drug dose will be. Some clinics have in-house pharmacies with bundled pricing, while others send you to a specialty pharmacy where prices fluctuate.

Common Add-Ons and What They Cost

Beyond the base cycle and medications, most patients encounter a menu of optional or recommended add-on procedures, each with its own price tag. Not all of them are medically necessary for every patient, and the evidence behind some is stronger than others.

ICSI: Intracytoplasmic sperm injection, where a single sperm is injected directly into each egg, is standard for male-factor infertility but also routinely offered to couples without sperm issues. It typically adds $1,500 to $3,000 per cycle. An Australian cost-effectiveness study estimated that the added cost per procedure could be as low as a few hundred dollars for patients with abnormal semen parameters, though total incremental costs scale up when ICSI is used broadly across all patient types.⁵
Genetic testing (PGT-A): Preimplantation genetic testing for aneuploidies screens embryos for chromosomal abnormalities before transfer. It commonly costs $3,000 to $6,000 depending on how many embryos are tested. Research has examined whether the upfront cost is offset by fewer failed transfers and miscarriages, but the cost-effectiveness depends heavily on patient age and how many embryos are available.⁶
Embryo freezing and storage: Cryopreserving extra embryos for future use typically costs $1,000 to $2,000 for the initial freeze, plus annual storage fees ranging from $500 to $1,000. These recurring charges add up over years and have become an increasing financial and logistical concern for both patients and clinics as the number of stored embryos grows.
Frozen embryo transfer: If you freeze embryos and return for a subsequent transfer instead of doing a fresh one, the transfer cycle itself typically costs $3,000 to $5,000, far less than a full stimulation cycle but still a meaningful expense.

When clinics quote an “all-inclusive” IVF package, check carefully what is actually included. Some bundles cover ICSI and basic monitoring but exclude genetic testing and freezing. Others include the first year of storage but not subsequent years. Asking for a line-item breakdown before signing anything is worth the awkwardness.

How Your Age Changes the Total Price Tag

The single biggest factor in how much you’ll spend on IVF overall is not the clinic’s per-cycle pricing. It’s how many cycles you need, and that depends heavily on age. A cost-effectiveness analysis found that the incremental cost per live birth ranged from about AU$27,000 to AU$32,000 for women aged 30 to 33 on their first through third cycles. For women aged 42 to 45, that cost jumped to between AU$131,000 and AU$188,000.⁷ The takeaway: maternal age has a far larger effect on cost-per-baby than the number of attempts does.

This pattern exists because success rates per cycle drop sharply with age. Standard IVF with a woman’s own eggs has a cumulative live birth rate of about 45% at age 35 using multiple attempts, but that plummets to under 2% by age 45.⁸ That means an older patient is likely to go through more cycles, more medications, more monitoring, and more emotional wear before either succeeding or switching strategies (such as donor eggs). If you’re budgeting at 38 or older, planning for two to four full cycles is more realistic than hoping one will work.

Insurance, Employer Benefits, and Who Actually Pays

Whether insurance covers any of your IVF costs depends almost entirely on where you live and who employs you. A handful of U.S. states have mandates requiring insurers to cover or offer fertility treatment, but the specifics vary widely. Some mandates cover only diagnostic testing and not IVF itself. Others cap coverage at a dollar amount or a limited number of cycles. Even in mandate states, many employer plans qualify for exemptions, leaving employees with no coverage at all.

Employer-sponsored fertility benefits have expanded in recent years, particularly at large technology and finance companies. These benefits can cover clinical treatments, egg and sperm freezing, genetic testing, and even non-clinical family-building support like adoption assistance.⁹ But they differ from standard health benefits in that they involve intensive medical coordination, strict privacy requirements, and high financial commitments from both the employer and the employee. If your employer offers a fertility benefit, read the details carefully: lifetime caps, which procedures are included, and whether you must use an in-network clinic can all limit the actual financial relief.

For patients without any coverage, the full cost lands squarely on the household. In the U.S., that means many couples are financing IVF out of savings, credit cards, home equity lines, or family loans. Understanding exactly what your plan covers (or doesn’t) before your first consultation saves time and prevents the gut-punch of a surprise bill after retrieval.

Refund Programs and Shared-Risk Plans

Many U.S. fertility clinics offer “shared-risk” or “refund” programs designed to spread the financial uncertainty across multiple cycles. These programs charge a higher upfront fee but cover multiple attempts. If treatment fails after an agreed number of cycles, you get a partial or complete refund.¹⁰ A typical multi-cycle package might cost $20,000 to $35,000 upfront for two or three fresh cycles plus any associated frozen transfers.

The appeal is obvious: you’re capping your worst-case financial exposure. But these plans have trade-offs worth understanding. Clinics screen applicants for eligibility, and patients with the lowest odds of success (older age, diminished ovarian reserve, repeated failures) are often excluded from refund programs. That means the patients who most need financial protection are the least likely to qualify. Additionally, if you succeed on the first cycle, you’ve overpaid compared to what you would have spent paying per cycle. These programs function a bit like insurance: they’re a good deal if things go badly and a worse deal if they go well. Whether that trade-off makes sense depends on your financial situation and risk tolerance.

When “Cheaper” Treatments End Up Costing More

A common assumption is that you should try less expensive treatments like intrauterine insemination (IUI) before escalating to IVF. That logic makes sense on a per-cycle basis, since a single IUI cycle typically costs a fraction of what IVF does. But the math can reverse when you calculate cost per live birth, because IUI’s per-cycle success rates are much lower for many diagnoses. A randomized trial comparing the two approaches in patients with unexplained or mild male infertility found the cost per live birth was about AU$8,700 for IVF versus roughly AU$42,500 for IUI.¹¹

That counterintuitive result happens because patients randomized to IUI needed many more cycles (and often eventually crossed over to IVF anyway) before achieving a live birth. For certain diagnoses, going straight to IVF is not the more aggressive option; it’s the more efficient one. This doesn’t apply universally. Younger patients with unexplained infertility and open fallopian tubes may do well with a few IUI cycles first. But if your doctor is recommending IVF upfront, the financial reasoning behind that recommendation is often stronger than it appears.

Lower-Cost Protocols

Not all IVF cycles involve the same level of hormonal stimulation, and gentler protocols cost less. Minimal stimulation IVF, sometimes called “mini-IVF,” uses lower doses of fertility drugs or oral medications instead of high-dose injectables. A study comparing minimal and conventional stimulation in patients with low ovarian reserve found that medication costs alone were about €1,260 lower per cycle with the minimal approach, largely because the total drug dose was cut roughly in half.¹²

The catch is that minimal stimulation typically produces fewer eggs per cycle, which means fewer embryos and potentially fewer chances per retrieval. For some patients, particularly those who respond poorly to high doses anyway, the trade-off is worth it: you’re spending less on drugs that weren’t producing proportionally more eggs. For patients who respond well to conventional stimulation, the higher upfront cost may deliver better bang for the buck by creating more embryos that can be frozen and transferred in less expensive subsequent cycles. Your doctor can help you weigh whether a lower per-cycle cost or a higher per-cycle yield is the better financial strategy for your situation.

Traveling Abroad for Treatment

Cross-border reproductive travel has become a significant phenomenon, driven largely by the stark cost differences between countries.¹³ Patients travel not just for lower prices but also for access to treatments restricted in their home country, shorter wait times, or the ability to combine donor gametes with IVF in jurisdictions with more permissive regulations.

Countries like the Czech Republic, Spain, Greece, Turkey, and India have become popular destinations. In Turkey, for instance, the total cost of an IVF cycle including travel and lodging can still come in well below what a domestic cycle costs in the U.S.³ But overseas treatment introduces complications: coordinating care across time zones, managing follow-up monitoring with a local doctor at home, navigating different regulatory standards, and dealing with the emotional strain of undergoing medical procedures far from your support network. Some patients do multiple cycles abroad and report substantial savings; others find the logistical friction wipes out part of the financial advantage.

Costs Don’t Stop at a Positive Test

Budget planning for IVF tends to focus on what it takes to get pregnant, but the costs that follow conception are worth thinking about, especially because IVF pregnancies carry a somewhat higher rate of multiple gestations (twins in particular) even with current single-embryo transfer practices. A European study found that total prenatal and neonatal healthcare costs for an IVF singleton were about €5,800, while an IVF twin pregnancy cost roughly €15,600, nearly triple.¹⁴ The biggest driver of that difference was the higher rate of preterm birth and NICU admission in multiples.

This is one of the strongest financial arguments for single-embryo transfer, even when patients feel tempted to transfer two embryos to maximize their chances per cycle. Reducing multiple pregnancies is the most effective lever for bringing down the downstream healthcare costs of IVF.¹⁵ Even if single-embryo transfer means you need an additional frozen transfer cycle, the combined cost of that extra transfer plus a lower-risk singleton pregnancy is often less than the medical bills from a twin pregnancy with complications.

The Financial Stress Factor

IVF’s financial weight doesn’t exist in a vacuum. It compounds an already emotionally taxing process, and the research suggests that the financial burden directly affects whether people continue treatment. A study found that lacking insurance coverage roughly doubled the odds that a patient would be unwilling to continue IVF, independent of clinical prognosis. Patients screening positive for anxiety or depression were about twice as likely to drop out as well.¹⁶ Financial stress and emotional distress feed each other in a loop that can push people to stop treatment before they’ve exhausted their realistic chances.

Even in systems designed to reduce the financial barrier, dropout remains a real issue. In New Zealand, which has a publicly funded IVF system, about 10% of couples still discontinued between their first and second cycles for stress-related reasons.¹⁷ When cost is layered on top of that stress, the attrition rate climbs. Budgeting realistically for IVF means not just accounting for the dollar amounts but also building in enough financial cushion that the decision to continue or stop treatment after each cycle can be a medical and personal one rather than one forced by an empty bank account.

Putting a Realistic Number on It

If you’re in the U.S. without insurance coverage, a reasonable budgeting range for a first cycle including medications, monitoring, retrieval, fertilization, and transfer is $15,000 to $25,000. Add ICSI and you’re looking at another $1,500 to $3,000. Genetic testing can push the total above $25,000 for a single cycle. Embryo freezing and annual storage tack on $1,500 to $3,000 in the first year and $500 to $1,000 each year after. A frozen embryo transfer cycle, if needed later, adds another $3,000 to $5,000.

Most patients under 35 should plan for one to three cycles. Patients between 35 and 40 should budget for two to four. Over 40, the math gets steep enough that shared-risk programs, donor eggs, or overseas treatment all become worth exploring seriously. The cost per live birth data is sobering at older ages: the amount required to bring home a baby can increase fivefold or more between a patient’s early thirties and early forties.⁷ That is not a reason to avoid IVF at an older age, but it is a reason to go in with clear financial boundaries and a plan for what happens if the first or second cycle doesn’t work.

Build your budget as a total project cost, not a per-cycle cost. Include medications, add-ons, storage fees, the possibility of multiple transfers, and some buffer for unexpected complications like ovarian hyperstimulation that may require additional monitoring or a freeze-all strategy that pushes your transfer to a later cycle. Having the full picture upfront won’t make IVF cheap, but it prevents the particular misery of running out of funds mid-treatment and having to make rushed decisions about whether to keep going.